Back to User profile » Dr Yoshinobu Okuno
Papers published by Dr Yoshinobu Okuno:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
Onodera H, Urayama T, Hirota K, Maeda K, Kubota-Koketsu R, Takahashi K, Hagiwara K, Okuno Y, Ikuta K, Yunoki M
Biologics: Targets and Therapy 2017, 11:23-30
Published Date: 10 March 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus
Yunoki M, Kurosu T, Koketsu RK, Takahashi K, Okuno Y, Ikuta K
Biologics: Targets and Therapy 2016, 10:99-102
Published Date: 7 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus
Ideno S, Sakai K, Yunoki M, Kubota-Koketsu R, Inoue Y, Nakamura S, Yasunaga T, Okuno Y, Ikuta K
Biologics: Targets and Therapy 2013, 7:233-241
Published Date: 5 November 2013
![Noteworthy comment: This study demonstrates that viral neutralizing activities (VN) of human intravenous immunoglobulin (IVIG) against the Influenza A H2N2 virus, also known as the Asian flu, correlates with the history of infection and vaccine program of the donating population in Japan. This study demonstrates that evaluation of antibody titers in donated](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010
Kubota-Koketsu R, Yunoki M, Okuno Y, Ikuta K
Biologics: Targets and Therapy 2012, 6:245-247
Published Date: 27 July 2012